menu
    • menu

    Company profile for Homology Medicines

    NEW Drugs in Dev: 6
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Homology Medicines, Inc. is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology’s proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo ei...
    Homology Medicines, Inc. is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology’s proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Homology MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Homology Medicines, Inc. 1 Patriots Park Bedford, MA 01730
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.homologymedicines.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Q32 Bio Announces Closing of Merger with Homology & Placement of $42M
    Q32 Bio Announces Closing of Merger with Homology & Placement of $42M

    25 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/q32-bio-announces-closing-of-merger-with-homology-medicines-and-concurrent-private-placement-of-42-million-302098557.html

    PR NEWSWIRE
    25 Mar 2024
    Share Share
    Homology Medicines Declares Distribution to Common Stockholders
    Homology Medicines Declares Distribution to Common Stockholders

    18 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/18/2848184/0/en/Homology-Medicines-Declares-Distribution-to-Common-Stockholders.html

    GLOBENEWSWIRE
    18 Mar 2024
    Share Share
    Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price
    Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price

    03 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/03/2803627/0/en/Homology-Medicines-Receives-NASDAQ-Notification-Regarding-Minimum-Bid-Price-Deficiency.html

    GLOBENEWSWIRE
    03 Jan 2024
    Share Share
    Q32 Bio and Homology Medicines Announce Merger Agreement
    Q32 Bio and Homology Medicines Announce Merger Agreement

    16 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/16/2781720/0/en/Q32-Bio-and-Homology-Medicines-Announce-Merger-Agreement.html

    GLOBENEWSWIRE
    16 Nov 2023
    Share Share
    Homology Medicines Reports Third Quarter 2023 Financial Results
    Homology Medicines Reports Third Quarter 2023 Financial Results

    14 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/14/2780577/0/en/Homology-Medicines-Reports-Third-Quarter-2023-Financial-Results.html

    GLOBENEWSWIRE
    14 Nov 2023
    Share Share
    Homology Medicines Reports Second Quarter 2023 Financial Results
    Homology Medicines Reports Second Quarter 2023 Financial Results

    14 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/14/2724999/0/en/Homology-Medicines-Reports-Second-Quarter-2023-Financial-Results-and-Recent-Highlights.html

    GLOBENEWSWIRE
    14 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search